Skip to content

Exponent EXPO Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

PDF Solutions logo
PDF SolutionsPDFS

Other financials

Income statement

See full
Revenue$166.3M+14.3%
Operating income$41.4M-6.9%
Net income$29.6M+11.0%
EPS (diluted)$0.59+13.5%

Balance sheet

See full
Cash & equivalents$118.6M-51.6%
Total debt$81.0M+1.1%
Total equity$338.3M-23.4%
Total assets$687.4M-9.9%

Cash flow

See full
Operating cash flow-$975.0K-113%
CapEx$2.5M+39.9%
Free cash flow-$3.4M-162%

Valuation

See full
Market cap$2.78B-18.9%
Enterprise value$2.74B-16.4%
P/E25.5×-7.0×
P/S4.6×-1.5×

Profitability

See full
Operating margin19.4%-4.5pp
Net margin18.1%-0.8pp
FCF margin18.8%-5.2pp

Returns & leverage

See full
Return on equity27.9%+2.1pp
Debt / equity0.2×+0.1×
Current ratio2.4×-0.9×

Where this comes from

Reported directly by Exponent in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Exponent’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exponent's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exponent's proceeds from exercises of stock options and other stock issuances?
Exponent (EXPO) reported proceeds from exercises of stock options and other stock issuances of $777K in Q1 2026.
How has Exponent's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Exponent's proceeds from exercises of stock options and other stock issuances increased by 60.5% year-over-year, from $484K to $777K.
What is the long-term trend for Exponent's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Exponent's proceeds from exercises of stock options and other stock issuances has grown at a -6.6% compound annual growth rate (CAGR), from $3.11M to $2.37M.